In-hospital outcome and its predictors among patients with acute cardiogenic pulmonary oedema at a tertiary hospital in Harar, Eastern Ethiopia: a retrospective cohort study

IF 3.3 Q1 HEALTH POLICY & SERVICES Journal of Pharmaceutical Policy and Practice Pub Date : 2024-02-22 DOI:10.1080/20523211.2024.2309294
Natanim Degefu, A. Jambo, Lemma Demissie Regassa, Melaku Getachew
{"title":"In-hospital outcome and its predictors among patients with acute cardiogenic pulmonary oedema at a tertiary hospital in Harar, Eastern Ethiopia: a retrospective cohort study","authors":"Natanim Degefu, A. Jambo, Lemma Demissie Regassa, Melaku Getachew","doi":"10.1080/20523211.2024.2309294","DOIUrl":null,"url":null,"abstract":"ABSTRACT Background: Acute cardiogenic pulmonary oedema is highly associated with poor in-hospital outcomes. This study aimed to determine the in-hospital outcome and its predictors among patients with acute cardiogenic pulmonary oedema at a tertiary hospital in Harar, Eastern Ethiopia, from May 1 to 20, 2023. Methods: A retrospective cohort study was employed among 204 patients with acute cardiogenic pulmonary oedema who were admitted between 1st May 2018 and 30th April 2023. The collected data were entered into Excel, and analysed using theSTATA software version 17. The hazard ratio with its 95% confidence interval was used and a P-value < 0.05 was considered a statistically significant association. Results: The overall mortality rate was 17.60 (95% CI: 11.59–26.72) per 1000 person-day observation with mean (±SD) time to death was 2.88 (±2.06) days. Age (AHR: 1.35; 95% CI: 1.04–1.74 for every 10 years), being smoker (AHR: 3.26; 95% CI: 1.05–10.10), having respiratory rate of ≥40 breaths per minute (AHR: 5.46; 95% CI: 1.71–17.45), and having anaemia (AHR: 4.35; 95% CI: 1.23–15.33) were significant predictors of in-hospital mortality. Conclusion: More than one in ten patients in this study died in the hospital. Therefore, special attention needs to be considered for patients with those predictors of in-hospital mortality.","PeriodicalId":16740,"journal":{"name":"Journal of Pharmaceutical Policy and Practice","volume":null,"pages":null},"PeriodicalIF":3.3000,"publicationDate":"2024-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Policy and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/20523211.2024.2309294","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

ABSTRACT Background: Acute cardiogenic pulmonary oedema is highly associated with poor in-hospital outcomes. This study aimed to determine the in-hospital outcome and its predictors among patients with acute cardiogenic pulmonary oedema at a tertiary hospital in Harar, Eastern Ethiopia, from May 1 to 20, 2023. Methods: A retrospective cohort study was employed among 204 patients with acute cardiogenic pulmonary oedema who were admitted between 1st May 2018 and 30th April 2023. The collected data were entered into Excel, and analysed using theSTATA software version 17. The hazard ratio with its 95% confidence interval was used and a P-value < 0.05 was considered a statistically significant association. Results: The overall mortality rate was 17.60 (95% CI: 11.59–26.72) per 1000 person-day observation with mean (±SD) time to death was 2.88 (±2.06) days. Age (AHR: 1.35; 95% CI: 1.04–1.74 for every 10 years), being smoker (AHR: 3.26; 95% CI: 1.05–10.10), having respiratory rate of ≥40 breaths per minute (AHR: 5.46; 95% CI: 1.71–17.45), and having anaemia (AHR: 4.35; 95% CI: 1.23–15.33) were significant predictors of in-hospital mortality. Conclusion: More than one in ten patients in this study died in the hospital. Therefore, special attention needs to be considered for patients with those predictors of in-hospital mortality.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
埃塞俄比亚东部哈拉尔一家三级医院急性心源性肺水肿患者的院内预后及其预测因素:一项回顾性队列研究
摘要 背景:急性心源性肺水肿与不良的院内预后密切相关。本研究旨在确定埃塞俄比亚东部哈拉尔一家三级医院 2023 年 5 月 1 日至 20 日期间急性心源性肺水肿患者的院内预后及其预测因素。研究方法对2018年5月1日至2023年4月30日期间收治的204名急性心源性肺水肿患者进行回顾性队列研究。收集的数据输入Excel,并使用STATA软件17版进行分析。使用危险比及其95%置信区间,P值小于0.05视为有统计学意义的关联。结果总死亡率为每千人观察日 17.60(95% CI:11.59-26.72),平均(±SD)死亡时间为 2.88(±2.06)天。年龄(AHR:1.35;95% CI:每 10 年 1.04-1.74)、吸烟(AHR:3.26;95% CI:1.05-10.10)、呼吸频率≥40 次/分钟(AHR:5.46;95% CI:1.71-17.45)和贫血(AHR:4.35;95% CI:1.23-15.33)是院内死亡率的重要预测因素。结论本研究中有超过十分之一的患者死于医院。因此,需要特别关注有这些院内死亡预测因素的患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Pharmaceutical Policy and Practice
Journal of Pharmaceutical Policy and Practice Health Professions-Pharmacy
CiteScore
4.70
自引率
9.50%
发文量
81
审稿时长
14 weeks
期刊最新文献
A quantitative investigation in a territory of Italy on citizens' attitudes towards medicines through the COVID-19 pandemic: the importance of possible indirect effects caused by the pandemic. Cost-effectiveness analysis of genotype-guided optimization of major depression treatment in Qatar. Exploring the influencing factors of adverse drug reaction reporting among medical personnel: a COM-B model-based study. Pharmacovigilance: the evolution of drug safety monitoring. Inhaler personalisation based on peak inspiratory flow (PIF) among dry powder inhaler users: a pilot randomised control trial (RCT) in COPD.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1